• Home
  • CBD News
  • CBD Uses
  • CBD Products
  • Contact Us
No Result
View All Result
Cbdnewshubb
Advertisement Banner
  • Home
  • CBD News
  • CBD Uses
  • CBD Products
  • Contact Us
No Result
View All Result
Cbdnewshubb
No Result
View All Result
Home CBD Uses

From Psilocybin to Ketamine: Alberta to Regulate Psychoactive Therapy

admin by admin
December 7, 2022
in CBD Uses


In January 2023, Alberta will become the first Canadian province to have a regulated psychedelic therapy program for patients suffering from mental health conditions. This comes after the government amended the Mental Health Services Protection Regulation in October to make special provisions and requirements for psychedelic assisted therapy. The psychedelics in question include psilocybin, LSD, mescaline, peyote, psilocin, DMT, and Ketamine.

The new amendment will allow psychiatrists with a license under the Mental Health Services Protection Act to offer psychedelics to patients. Administration of the psychedelic therapy will only take place in a closed clinical environment, except in cases of end of life care.

The amendment only applies to psychedelic assisted therapy for psychiatric disorders. It does not apply to the use of psychedelics in clinical trials, for the treatment of pain (ketamine therapy) or for use in end of life care.

Even though psychedelics are illegal in Canada, they have remained accessible to scientists for research purposes. Current research has shown that certain psychedelics have significant therapeutic potential in psychiatry and especially PTSD and treatment resistant depression (TRD). A randomized clinical trial that was published in 2020 showed that psilocybin is efficacious in treating severe depression.

However, researchers are aware that psychedelics carry risks and have a high potential for abuse, therefore their use in the clinical setting should be monitored. The government of Alberta has put measures in place to safeguard the health and safety of patients.



Source link

Previous Post

High On Terpenes: Aroma, Not THC Levels, Determine the Subjective Appeal of Cannabis

Next Post

Understanding Product Label and Potency Discrepancies

Next Post

Understanding Product Label and Potency Discrepancies

What Is The Legal Age For Psilocybin In The United States?

5WPR Announces Continued Expansion of Cannabis & CBD PR Team Following

Popular Post

What Are the Benefits of CBD for Depression?

by admin
January 27, 2023

Delta-8-THC Businesses Have Raked in $2 Billion Since 2020

by admin
January 27, 2023

Adaptive Athlete Ski Camp High Fives Foundation

by admin
January 27, 2023

People Science Raises $5.3 Million To Revolutionize The Way Alternative

by admin
January 26, 2023

Should I Take CBD Before Or After A Workout?

by admin
January 26, 2023

Is Kratom Legal in the U.S.?

by admin
January 26, 2023

cbd-44

© 2022 CBD News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • CBD News
  • CBD Uses
  • CBD Products
  • Contact Us

Newsletter Sign Up.

No Result
View All Result
  • Home
  • CBD News
  • CBD Uses
  • CBD Products
  • Contact Us

© 2022 CBD News Hubb All rights reserved.